Leading the Way in Life Science Technologies

GEN Exclusives

More »

Companies

More »

Updated: Aug 13 2012

Cellectis bioresearch

  • Cellectis bioresearch
  • 8 rue de la Croix Jarry
  • Paris, 75013
  • FRANCE

Cellectis bioresearch’s mission is to provide easy access to Meganucleases and their enabling potential to modify the DNA sequence of a target genome with high precision. Meganucleases are highly specific DNA endonucleases which provide the biotechnology industry with a full set of Genome Customization tools.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »